You just read:

EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)

News provided by

EIP Pharma, Inc.

Nov 07, 2019, 07:00 ET